New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareVesugen vs Syn-Ake

Vesugen vs Syn-Ake

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Vesugen
Skin & CosmeticAnti-Aging & Longevity
Syn-Ake
Summary
Vesugen is a tripeptide bioregulator (Lys-Glu-Asp) developed by Professor Vladimir Khavinson, tissue-specific for blood vessels and the vascular endothelium. It supports endothelial cell function, promotes vascular wall integrity, and is studied for atherosclerosis prevention, vascular aging, and cardiovascular health maintenance. It is one of the more broadly applicable Khavinson bioregulators given the ubiquity of vascular tissue.
Syn-Ake is a synthetic tripeptide that mimics waglerin-1, a peptide found in the venom of the Temple viper (Tropidolaemus wagleri). It acts as a reversible antagonist of muscular nicotinic acetylcholine receptors, temporarily reducing facial muscle contraction and smoothing dynamic wrinkles. Often called a 'synthetic Botox' in cosmetic marketing.
Half-Life
Short (minutes); sustained gene-regulatory effects
Not applicable (topical; effect duration hours)
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
0.01–0.1% (4–8 mg/g in clinical studies)
Frequency
Daily for 10–30 days
Twice daily
Key Benefits
  • Supports vascular endothelial cell function and integrity
  • May reduce endothelial inflammation and dysfunction
  • Anti-aging effects on blood vessel walls
  • Potential benefits in early atherosclerosis and vascular aging
  • Supports nitric oxide-mediated vascular tone
  • Reduces endothelial apoptosis from oxidative stress
  • Complementary to Cardiogen and Epithalon in cardiovascular longevity protocols
  • Reduces depth of dynamic wrinkles and expression lines
  • Reversible muscle-relaxing effect on facial muscles
  • Smooths forehead lines, crow's feet, and frown lines
  • Non-invasive alternative to injectable neurotoxins
  • Rapid onset relative to collagen-stimulating peptides
  • Well-studied in in vitro and clinical cosmetic trials
Side Effects
  • Generally well tolerated
  • Mild injection site reactions
  • No significant vascular adverse events reported at standard doses
  • Generally very well-tolerated topically
  • Rare skin sensitivity or contact dermatitis
  • Theoretical neuromuscular effects at systemic doses (not relevant topically)
Stacks With